Have a Little Fun!

Teva Launches Generic Focalin XR

Teva announced the launch of Dexmethylphenidate HCl Extended-Release Capsules, the generic version of Novartis'Focalin XR.

Dexmethylphenidate HCl is a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD). Dexmethylphenidate, the more pharmacologically active d-enantiomer of racemic methylphenidate, is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.